Samuel George A. III
Insider CIK 1878732 · LCTX General Counsel/Secretary
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| LCTX Lineage Cell Therapeutics, | A Award deriv | 2026-03-05 | 2026-03-06 | 900,000 | — | $0 | 900,000 | SEC↗ |
| LCTX Lineage Cell Therapeutics, | M Exercise deriv | 2026-02-11 | 2026-02-13 | 6,075 | — | $0 | 0 | SEC↗ |
| LCTX Lineage Cell Therapeutics, | F Tax w/h | 2026-02-11 | 2026-02-13 | 2,502 | $1.80 | $4.5K | 31,063 | SEC↗ |
| LCTX Lineage Cell Therapeutics, | M Exercise | 2026-02-11 | 2026-02-13 | 6,075 | — | $0 | 33,565 | SEC↗ |
| LCTX Lineage Cell Therapeutics, | F Tax w/h | 2025-12-19 | 2025-12-19 | 65 | $1.68 | $109 | 27,490 | SEC↗ |
| LCTX Lineage Cell Therapeutics, | A Award | 2025-12-19 | 2025-12-19 | 1,735 | — | $0 | 27,555 | SEC↗ |
| LCTX Lineage Cell Therapeutics, | A Award deriv | 2025-03-10 | 2025-03-12 | 750,000 | — | $0 | 750,000 | SEC↗ |
| LCTX Lineage Cell Therapeutics, | M Exercise deriv | 2025-02-11 | 2025-02-12 | 6,076 | — | $0 | 6,075 | SEC↗ |
| LCTX Lineage Cell Therapeutics, | F Tax w/h | 2025-02-11 | 2025-02-12 | 2,440 | $0.65 | $1.6K | 25,820 | SEC↗ |
| LCTX Lineage Cell Therapeutics, | M Exercise | 2025-02-11 | 2025-02-12 | 6,076 | — | $0 | 28,260 | SEC↗ |
| LCTX Lineage Cell Therapeutics, | P Buy | 2024-11-26 | 2024-11-26 | 15,000 | $0.60 | $9.0K | 22,184 | SEC↗ |
| LCTX Lineage Cell Therapeutics, | A Award deriv | 2024-03-07 | 2024-03-08 | 650,000 | — | $0 | 650,000 | SEC↗ |
| LCTX Lineage Cell Therapeutics, | M Exercise deriv | 2024-02-11 | 2024-02-12 | 6,076 | — | $0 | 12,151 | SEC↗ |
| LCTX Lineage Cell Therapeutics, | F Tax w/h | 2024-02-11 | 2024-02-12 | 2,490 | $1.08 | $2.7K | 7,184 | SEC↗ |
| LCTX Lineage Cell Therapeutics, | M Exercise | 2024-02-11 | 2024-02-12 | 6,076 | — | $0 | 9,674 | SEC↗ |
| LCTX Lineage Cell Therapeutics, | A Award deriv | 2023-03-09 | 2023-03-10 | 650,000 | — | $0 | 650,000 | SEC↗ |
| LCTX Lineage Cell Therapeutics, | M Exercise deriv | 2023-02-11 | 2023-02-14 | 6,076 | — | $0 | 18,227 | SEC↗ |
| LCTX Lineage Cell Therapeutics, | F Tax w/h | 2023-02-11 | 2023-02-14 | 2,478 | $1.35 | $3.3K | 3,598 | SEC↗ |
| LCTX Lineage Cell Therapeutics, | M Exercise | 2023-02-11 | 2023-02-14 | 6,076 | — | $0 | 6,076 | SEC↗ |
| LCTX Lineage Cell Therapeutics, | A Award deriv | 2022-03-10 | 2022-03-11 | 650,000 | — | $0 | 650,000 | SEC↗ |
| LCTX Lineage Cell Therapeutics, | A Award deriv | 2022-02-11 | 2022-02-15 | 24,303 | — | $0 | 24,303 | SEC↗ |
| LCTX Lineage Cell Therapeutics, | A Award deriv | 2021-09-01 | 2021-09-02 | 695,000 | — | $0 | 695,000 | SEC↗ |